EUVIMEDEUVIMED entdecken
Open Access

Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance—Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004–2018

Louise K Francois Watkins iD, Sarah Luna, Beau B Bruce, Felicita Medalla, Jared L Reynolds, Logan C Ray, Elisha L Wilson, Hayat Caidi, Patricia M Griffin

Clinical Infectious Diseases · 20.03.2024 · 78 (3) · 535-543

DOI: 10.1093/cid/ciad631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 12.10.2023. Verfasst von Louise K Francois Watkins und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Salmonella Infections, Foodborne Diseases, Anti-Infective Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, CDC Emerging Infections Program, Colorado Department of Public Health and Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nontyphoidal Salmonella causes an estimated 1.35 million US infections annually. Antimicrobial-resistant strains are a serious public health threat. We examined the association between resistance and the clinical outcomes of hospitalization, length-of-stay ≥3 days, and death.

Methods

We linked epidemiologic data from the Foodborne Diseases Active Surveillance Network with antimicrobial resistance data from the National Antimicrobial Resistance Monitoring System (NARMS) for nontyphoidal Salmonella infections from 2004 to 2018. We defined any resistance as resistance to ≥1 antimicrobial and clinical resistance as resistance to ampicillin, azithromycin, ceftriaxone, ciprofloxacin, or trimethoprim-sulfamethoxazole (for the subset of isolates tested for all 5 agents). We compared outcomes before and after adjusting for age, state, race/ethnicity, international travel, outbreak association, and isolate serotype and source.

Results

Twenty percent of isolates (1105/5549) had any resistance, and 16% (469/2969) had clinical resistance. Persons whose isolates had any resistance were more likely to be hospitalized (31% vs 28%, P = .01) or have length-of-stay ≥3 days (20% vs 16%, P = .01). Deaths were rare but more common among those with any than no resistance (1.0% vs 0.4%, P = .01). Outcomes for patients whose isolates had clinical resistance did not differ significantly from those with no resistance. After adjustment, any resistance (adjusted odds ratio 1.23, 95% confidence interval 1.04–1.46) remained significantly associated with hospitalization.

Conclusions

We observed a significant association between nontyphoidal Salmonella infections caused by resistant pathogens and likelihood of hospitalization. Clinical resistance was not associated with poorer outcomes, suggesting that factors other than treatment failure (eg, strain virulence, strain source, host factors) may be important.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salmonella InfectionsFoodborne DiseasesAnti-Infective AgentsHumansAnti-Bacterial AgentsWatchful WaitingMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Salmonelladeathdrug resistancehospitalizationlength of stay

Substanzen

Anti-Bacterial AgentsAnti-Infective Agents

Autor:innen und Institutionen

  • Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Colorado Department of Public Health & Environment, Denver, Colorado, USA.

ORCID-Profile: Louise K Francois Watkins

Förderung

  • Intramural CDC HHS
  • CDC Emerging Infections Program
  • Colorado Department of Public Health and Environment

Zitieren

APA

Francois Watkins, L. K., Luna, S., Bruce, B. B., Medalla, F., Reynolds, J. L., Ray, L. C., Wilson, E. L., Caidi, H., & Griffin, P. M. (2024). Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance—Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004–2018. Clinical Infectious Diseases, 78(3), 535-543. https://doi.org/10.1093/cid/ciad631

Vancouver

Francois Watkins LK, Luna S, Bruce BB, Medalla F, Reynolds JL, Ray LC, et al. Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance—Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004–2018. Clinical Infectious Diseases. 2024;78(3):535-543. doi:10.1093/cid/ciad631

BibTeX
@article{FrancoisWatkins2024,
  author = {Francois Watkins, Louise K and Luna, Sarah and Bruce, Beau B and Medalla, Felicita and Reynolds, Jared L and Ray, Logan C and Wilson, Elisha L and Caidi, Hayat and Griffin, Patricia M},
  title = {Clinical Outcomes of Patients With Nontyphoidal Salmonella Infections by Isolate Resistance—Foodborne Diseases Active Surveillance Network, 10 US Sites, 2004–2018},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {78},
  number = {3},
  pages = {535--543},
  doi = {10.1093/cid/ciad631}
}
Kostenlos starten →